{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:49:08Z","timestamp":1790430548518,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:00:00Z","timestamp":1606435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:00:00Z","timestamp":1606435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Loss of muscle tone triggered by emotions is called cataplexy and is the pathognomonic symptom of narcolepsy, which is caused by hypocretin deficiency. Cataplexy is classically considered to be an abnormal manifestation of REM sleep and is treated by selective serotonin (5HT) reuptake inhibitors. Here we show that deleting the 5HT transporter in hypocretin knockout mice suppressed cataplexy while dramatically increasing REM sleep. Additionally, double knockout mice showed a significant deficit in the buildup of sleep need. Deleting one allele of the 5HT transporter in hypocretin knockout mice strongly increased EEG theta power during REM sleep and theta and gamma powers during wakefulness. Deleting hypocretin receptors in the dorsal raphe neurons of adult mice did not induce cataplexy but consolidated REM sleep. Our results indicate that cataplexy and REM sleep are regulated by different mechanisms and both states and sleep need are regulated by the hypocretinergic input into 5HT neurons.<\/jats:p>","DOI":"10.1038\/s41467-020-19862-y","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T11:03:24Z","timestamp":1606475004000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Hypocretinergic interactions with the serotonergic system regulate REM sleep and cataplexy"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8380-1695","authenticated-orcid":false,"given":"Ali","family":"Seifinejad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Possovre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5314-5620","authenticated-orcid":false,"given":"Anne","family":"Vassalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6997-3914","authenticated-orcid":false,"given":"Mehdi","family":"Tafti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,27]]},"reference":[{"key":"19862_CR1","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41582-019-0226-9","volume":"15","author":"CLA Bassetti","year":"2019","unstructured":"Bassetti, C. L. A. et al. Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nat. Rev. Neurol. 15, 519\u2013539 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"19862_CR2","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1056\/NEJMra1500587","volume":"373","author":"TE Scammell","year":"2015","unstructured":"Scammell, T. E. Narcolepsy. N. Engl. J. Med. 373, 2654\u20132662 (2015).","journal-title":"N. Engl. J. Med."},{"key":"19862_CR3","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/79690","volume":"6","author":"C Peyron","year":"2000","unstructured":"Peyron, C. et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 6, 991\u2013997 (2000).","journal-title":"Nat. Med."},{"key":"19862_CR4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1474-4422(14)70218-2","volume":"14","author":"RS Liblau","year":"2015","unstructured":"Liblau, R. S., Vassalli, A., Seifinejad, A. & Tafti, M. Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy. Lancet Neurol. 14, 318\u2013328 (2015).","journal-title":"Lancet Neurol."},{"key":"19862_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41586-018-0540-1","volume":"562","author":"D Latorre","year":"2018","unstructured":"Latorre, D. et al. T cells in patients with narcolepsy target self-antigens of hypocretin neurons. Nature 562, 63\u201368 (2018).","journal-title":"Nature"},{"key":"19862_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08774-1","volume":"10","author":"NW Pedersen","year":"2019","unstructured":"Pedersen, N. W. et al. CD8(+) T cells from patients with narcolepsy and healthy controls recognize hypocretin neuron-specific antigens. Nat. Commun. 10, 837 (2019).","journal-title":"Nat. Commun."},{"key":"19862_CR7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","volume":"92","author":"T Sakurai","year":"1998","unstructured":"Sakurai, T. et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92, 573\u2013585 (1998).","journal-title":"Cell"},{"key":"19862_CR8","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1073\/pnas.95.1.322","volume":"95","author":"L de Lecea","year":"1998","unstructured":"de Lecea, L. et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl Acad. Sci. USA 95, 322\u2013327 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"19862_CR9","doi-asserted-by":"publisher","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","volume":"18","author":"C Peyron","year":"1998","unstructured":"Peyron, C. et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18, 9996\u201310015 (1998).","journal-title":"J. Neurosci."},{"key":"19862_CR10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","volume":"98","author":"RM Chemelli","year":"1999","unstructured":"Chemelli, R. M. et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98, 437\u2013451 (1999).","journal-title":"Cell"},{"key":"19862_CR11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0092-8674(00)81965-0","volume":"98","author":"L Lin","year":"1999","unstructured":"Lin, L. et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98, 365\u2013376 (1999).","journal-title":"Cell"},{"key":"19862_CR12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1113\/jphysiol.2003.052134","volume":"554","author":"MF Wu","year":"2004","unstructured":"Wu, M. F. et al. Activity of dorsal raphe cells across the sleep-waking cycle and during cataplexy in narcoleptic dogs. J. Physiol. 554, 202\u2013215 (2004).","journal-title":"J. Physiol."},{"key":"19862_CR13","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","volume":"71","author":"D Hoyer","year":"2002","unstructured":"Hoyer, D., Hannon, J. P. & Martin, G. R. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharm. Biochem. Behav. 71, 533\u2013554 (2002).","journal-title":"Pharm. Biochem. Behav."},{"key":"19862_CR14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.smrv.2004.01.004","volume":"8","author":"WC Houghton","year":"2004","unstructured":"Houghton, W. C., Scammell, T. E. & Thorpy, M. Pharmacotherapy for cataplexy. Sleep. Med. Rev. 8, 355\u2013366 (2004).","journal-title":"Sleep. Med. Rev."},{"key":"19862_CR15","doi-asserted-by":"publisher","unstructured":"Oikonomou, G. et al. The serotonergic raphe promote sleep in zebrafish and mice. Neuron https:\/\/doi.org\/10.1016\/j.neuron.2019.05.038 (2019).","DOI":"10.1016\/j.neuron.2019.05.038"},{"key":"19862_CR16","first-page":"24S","volume":"21","author":"M Jouvet","year":"1999","unstructured":"Jouvet, M. Sleep and serotonin: an unfinished story. Neuropsychopharmacology 21, 24S\u201327S (1999).","journal-title":"Neuropsychopharmacology"},{"key":"19862_CR17","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1523\/JNEUROSCI.19-08-03204.1999","volume":"19","author":"B Boutrel","year":"1999","unstructured":"Boutrel, B., Franc, B., Hen, R., Hamon, M. & Adrien, J. Key role of 5-HT1B receptors in the regulation of paradoxical sleep as evidenced in 5-HT1B knock-out mice. J. Neurosci. 19, 3204\u20133212 (1999).","journal-title":"J. Neurosci."},{"key":"19862_CR18","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.1523\/JNEUROSCI.22-11-04686.2002","volume":"22","author":"B Boutrel","year":"2002","unstructured":"Boutrel, B., Monaca, C., Hen, R., Hamon, M. & Adrien, J. Involvement of 5-HT1A receptors in homeostatic and stress-induced adaptive regulations of paradoxical sleep: studies in 5-HT1A knock-out mice. J. Neurosci. 22, 4686\u20134692 (2002).","journal-title":"J. Neurosci."},{"key":"19862_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/00001756-200302100-00015","volume":"14","author":"JP Wisor","year":"2003","unstructured":"Wisor, J. P. et al. Altered rapid eye movement sleep timing in serotonin transporter knockout mice. Neuroreport 14, 233\u2013238 (2003).","journal-title":"Neuroreport"},{"key":"19862_CR20","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1172\/JCI71017","volume":"124","author":"E Hasegawa","year":"2014","unstructured":"Hasegawa, E., Yanagisawa, M., Sakurai, T. & Mieda, M. Orexin neurons suppress narcolepsy via 2 distinct efferent pathways. J. Clin. Invest. 124, 604\u2013616 (2014).","journal-title":"J. Clin. Invest."},{"key":"19862_CR21","doi-asserted-by":"crossref","unstructured":"Gowda, C. R. & Lundt, L. P. Mechanism of action of narcolepsy medications. CNS Spectr. 19, 25\u201333; quiz 25\u201327, 34 (2014).","DOI":"10.1017\/S1092852914000583"},{"key":"19862_CR22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1124\/mol.53.4.649","volume":"53","author":"D Bengel","year":"1998","unstructured":"Bengel, D. et al. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine (\u201cEcstasy\u201d) in serotonin transporter-deficient mice. Mol. Pharm. 53, 649\u2013655 (1998).","journal-title":"Mol. Pharm."},{"key":"19862_CR23","doi-asserted-by":"publisher","first-page":"e32511","DOI":"10.1371\/journal.pone.0032511","volume":"7","author":"X Chen","year":"2012","unstructured":"Chen, X., Margolis, K. J., Gershon, M. D., Schwartz, G. J. & Sze, J. Y. Reduced serotonin reuptake transporter (SERT) function causes insulin resistance and hepatic steatosis independent of food intake. PLoS ONE 7, e32511 (2012).","journal-title":"PLoS ONE"},{"key":"19862_CR24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrn2284","volume":"9","author":"DL Murphy","year":"2008","unstructured":"Murphy, D. L. & Lesch, K. P. Targeting the murine serotonin transporter: insights into human neurobiology. Nat. Rev. Neurosci. 9, 85\u201396 (2008).","journal-title":"Nat. Rev. Neurosci."},{"key":"19862_CR25","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/brain\/awt069","volume":"136","author":"A Vassalli","year":"2013","unstructured":"Vassalli, A. et al. Electroencephalogram paroxysmal theta characterizes cataplexy in mice and children. Brain 136, 1592\u20131608 (2013).","journal-title":"Brain"},{"key":"19862_CR26","doi-asserted-by":"publisher","first-page":"E5464","DOI":"10.1073\/pnas.1700983114","volume":"114","author":"A Vassalli","year":"2017","unstructured":"Vassalli, A. & Franken, P. Hypocretin (orexin) is critical in sustaining theta\/gamma-rich waking behaviors that drive sleep need. Proc. Natl Acad. Sci. USA 114, E5464\u2013E5473 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"19862_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33069-8","volume":"8","author":"S Li","year":"2018","unstructured":"Li, S., Franken, P. & Vassalli, A. Bidirectional and context-dependent changes in theta and gamma oscillatory brain activity in noradrenergic cell-specific Hypocretin\/Orexin receptor 1-KO mice. Sci. Rep. 8, 15474 (2018).","journal-title":"Sci. Rep."},{"key":"19862_CR28","doi-asserted-by":"publisher","first-page":"20272","DOI":"10.1073\/pnas.1314762110","volume":"110","author":"SR Morairty","year":"2013","unstructured":"Morairty, S. R. et al. A role for cortical nNOS\/NK1 neurons in coupling homeostatic sleep drive to EEG slow wave activity. Proc. Natl Acad. Sci. USA 110, 20272\u201320277 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"19862_CR29","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1523\/JNEUROSCI.4845-04.2005","volume":"25","author":"C Cirelli","year":"2005","unstructured":"Cirelli, C., Huber, R., Gopalakrishnan, A., Southard, T. L. & Tononi, G. Locus ceruleus control of slow-wave homeostasis. J. Neurosci. 25, 4503\u20134511 (2005).","journal-title":"J. Neurosci."},{"key":"19862_CR30","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S0306-4522(02)00209-9","volume":"114","author":"C Cajochen","year":"2002","unstructured":"Cajochen, C., Wyatt, J. K., Czeisler, C. A. & Dijk, D. J. Separation of circadian and wake duration-dependent modulation of EEG activation during wakefulness. Neuroscience 114, 1047\u20131060 (2002).","journal-title":"Neuroscience"},{"key":"19862_CR31","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature06310","volume":"450","author":"AR Adamantidis","year":"2007","unstructured":"Adamantidis, A. R., Zhang, F., Aravanis, A. M., Deisseroth, K. & de Lecea, L. Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature 450, 420\u2013424 (2007).","journal-title":"Nature"},{"key":"19862_CR32","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3389\/fnins.2018.00535","volume":"12","author":"K Iwasaki","year":"2018","unstructured":"Iwasaki, K. et al. Ablation of central serotonergic neurons decreased REM sleep and attenuated arousal response. Front. Neurosci. 12, 535 (2018).","journal-title":"Front. Neurosci."},{"key":"19862_CR33","doi-asserted-by":"publisher","first-page":"7159","DOI":"10.1523\/JNEUROSCI.1027-04.2004","volume":"24","author":"Y Muraki","year":"2004","unstructured":"Muraki, Y. et al. Serotonergic regulation of the orexin\/hypocretin neurons through the 5-HT1A receptor. J. Neurosci. 24, 7159\u20137166 (2004).","journal-title":"J. Neurosci."},{"key":"19862_CR34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/cne.1190","volume":"435","author":"JN Marcus","year":"2001","unstructured":"Marcus, J. N. et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 435, 6\u201325 (2001).","journal-title":"J. Comp. Neurol."},{"key":"19862_CR35","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.5665\/sleep.2972","volume":"36","author":"S Tabuchi","year":"2013","unstructured":"Tabuchi, S. et al. Influence of inhibitory serotonergic inputs to orexin\/hypocretin neurons on the diurnal rhythm of sleep and wakefulness. Sleep 36, 1391\u20131404 (2013).","journal-title":"Sleep"},{"key":"19862_CR36","first-page":"119","volume":"1","author":"R Ursin","year":"1998","unstructured":"Ursin, R. & Bjorvatn, B. Sleep-wake and eeg effects following adenosine a1 agonism and antagonism: similarities and interactions with sleep-wake and eeg effects following a serotonin reuptake inhibitor in rats. Sleep. Res. Online 1, 119\u2013127 (1998).","journal-title":"Sleep. Res. Online"},{"key":"19862_CR37","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/BF02246410","volume":"126","author":"AL Sharpley","year":"1996","unstructured":"Sharpley, A. L. et al. The effects of paroxetine and nefazodone on sleep: a placebo controlled trial. Psychopharmacology 126, 50\u201354 (1996).","journal-title":"Psychopharmacology"},{"key":"19862_CR38","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0149-7634(05)80164-2","volume":"14","author":"G Vogel","year":"1990","unstructured":"Vogel, G., Neill, D., Hagler, M. & Kors, D. A new animal model of endogenous depression: a summary of present findings. Neurosci. Biobehav. Rev. 14, 85\u201391 (1990).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"19862_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fneur.2015.00123","volume":"6","author":"JJ Fraigne","year":"2015","unstructured":"Fraigne, J. J., Torontali, Z. A., Snow, M. B. & Peever, J. H. REM sleep at its core - circuits, neurotransmitters, and pathophysiology. Front. Neurol. 6, 123 (2015).","journal-title":"Front. Neurol."},{"key":"19862_CR40","doi-asserted-by":"publisher","first-page":"E3526","DOI":"10.1073\/pnas.1614552114","volume":"114","author":"E Hasegawa","year":"2017","unstructured":"Hasegawa, E. et al. Serotonin neurons in the dorsal raphe mediate the anticataplectic action of orexin neurons by reducing amygdala activity. Proc. Natl Acad. Sci. USA 114, E3526\u2013E3535 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"19862_CR41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jneumeth.2004.05.017","volume":"140","author":"TA Mathews","year":"2004","unstructured":"Mathews, T. A. et al. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. J. Neurosci. Methods 140, 169\u2013181 (2004).","journal-title":"J. Neurosci. Methods"},{"key":"19862_CR42","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1046\/j.1460-9568.2000.00126.x","volume":"12","author":"V Fabre","year":"2000","unstructured":"Fabre, V. et al. Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. Eur. J. Neurosci. 12, 2299\u20132310 (2000).","journal-title":"Eur. J. Neurosci."},{"key":"19862_CR43","doi-asserted-by":"publisher","first-page":"15575","DOI":"10.1523\/JNEUROSCI.3138-09.2009","volume":"29","author":"A Rachalski","year":"2009","unstructured":"Rachalski, A. et al. Altered sleep homeostasis after restraint stress in 5-HTT knock-out male mice: a role for hypocretins. J. Neurosci. 29, 15575\u201315585 (2009).","journal-title":"J. Neurosci."},{"key":"19862_CR44","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.1523\/JNEUROSCI.5156-05.2006","volume":"26","author":"C Alexandre","year":"2006","unstructured":"Alexandre, C. et al. Early life blockade of 5-hydroxytryptamine 1A receptors normalizes sleep and depression-like behavior in adult knock-out mice lacking the serotonin transporter. J. Neurosci. 26, 5554\u20135564 (2006).","journal-title":"J. Neurosci."},{"key":"19862_CR45","doi-asserted-by":"publisher","unstructured":"Soiza-Reilly, M. et al. SSRIs target prefrontal to raphe circuits during development modulating synaptic connectivity and emotional behavior. Mol. Psychiatry https:\/\/doi.org\/10.1038\/s41380-018-0260-9 (2018).","DOI":"10.1038\/s41380-018-0260-9"},{"key":"19862_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.147","volume":"5","author":"S Frazer","year":"2015","unstructured":"Frazer, S., Otomo, K. & Dayer, A. Early-life serotonin dysregulation affects the migration and positioning of cortical interneuron subtypes. Transl. Psychiatry 5, e644 (2015).","journal-title":"Transl. Psychiatry"},{"key":"19862_CR47","doi-asserted-by":"publisher","first-page":"9743","DOI":"10.1523\/JNEUROSCI.0499-13.2013","volume":"33","author":"Y Oishi","year":"2013","unstructured":"Oishi, Y. et al. Role of the medial prefrontal cortex in cataplexy. J. Neurosci. 33, 9743\u20139751 (2013).","journal-title":"J. Neurosci."},{"key":"19862_CR48","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3389\/fnins.2018.00892","volume":"12","author":"YC Saito","year":"2018","unstructured":"Saito, Y. C. et al. Serotonergic input to orexin neurons plays a role in maintaining wakefulness and REM sleep architecture. Front. Neurosci. 12, 892 (2018).","journal-title":"Front. Neurosci."},{"key":"19862_CR49","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.tips.2007.01.002","volume":"28","author":"AV Kalueff","year":"2007","unstructured":"Kalueff, A. V., Ren-Patterson, R. F. & Murphy, D. L. The developing use of heterozygous mutant mouse models in brain monoamine transporter research. Trends Pharm. Sci. 28, 122\u2013127 (2007).","journal-title":"Trends Pharm. Sci."},{"key":"19862_CR50","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1046\/j.1471-4159.2003.01836.x","volume":"86","author":"S Monta\u00f1ez","year":"2003","unstructured":"Monta\u00f1ez, S., Owens, W. A., Gould, G. G., Murphy, D. L. & Daws, L. C. Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice. J. Neurochem. 86, 210\u2013219 (2003).","journal-title":"J. Neurochem."},{"key":"19862_CR51","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/0301-0082(94)90005-1","volume":"44","author":"JH Benington","year":"1994","unstructured":"Benington, J. H. & Heller, H. C. Does the function of REM sleep concern non-REM sleep or waking? Prog. Neurobiol. 44, 433\u2013449 (1994).","journal-title":"Prog. Neurobiol."},{"key":"19862_CR52","first-page":"R1186","volume":"274","author":"T Endo","year":"1998","unstructured":"Endo, T. et al. Selective REM sleep deprivation in humans: effects on sleep and sleep EEG. Am. J. Physiol. 274, R1186\u2013R1194 (1998).","journal-title":"Am. J. Physiol."},{"key":"19862_CR53","first-page":"557","volume":"14","author":"AA Borbely","year":"1999","unstructured":"Borbely, A. A. & Achermann, P. Sleep homeostasis and models of sleep regulation. J. Biol. Rhythms 14, 557\u2013568 (1999).","journal-title":"J. Biol. Rhythms"},{"key":"19862_CR54","doi-asserted-by":"publisher","first-page":"314le312","DOI":"10.1126\/scitranslmed.aad2353","volume":"7","author":"A Vassalli","year":"2015","unstructured":"Vassalli, A., Li, S. & Tafti, M. Comment on \u201cAntibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2\u201d. Sci. Transl. Med. 7, 314le312 (2015).","journal-title":"Sci. Transl. Med."},{"key":"19862_CR55","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/9780470942390.mo110126","volume":"2","author":"GM Mang","year":"2012","unstructured":"Mang, G. M. & Franken, P. Sleep and EEG phenotyping in mice. Curr. Protoc. Mouse Biol. 2, 55\u201374 (2012).","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"19862_CR56","first-page":"R1127","volume":"275","author":"P Franken","year":"1998","unstructured":"Franken, P., Malafosse, A. & Tafti, M. Genetic variation in EEG activity during sleep in inbred mice. Am. J. Physiol. 275, R1127\u2013R1137 (1998).","journal-title":"Am. J. Physiol."},{"key":"19862_CR57","first-page":"155","volume":"22","author":"P Franken","year":"1999","unstructured":"Franken, P., Malafosse, A. & Tafti, M. Genetic determinants of sleep regulation in inbred mice. Sleep 22, 155\u2013169 (1999).","journal-title":"Sleep"},{"key":"19862_CR58","doi-asserted-by":"publisher","first-page":"195.e113","DOI":"10.1016\/j.neurobiolaging.2010.05.010","volume":"33","author":"S Hasan","year":"2012","unstructured":"Hasan, S., Dauvilliers, Y., Mongrain, V., Franken, P. & Tafti, M. Age-related changes in sleep in inbred mice are genotype dependent. Neurobiol. Aging 33, 195.e113\u2013126 (2012).","journal-title":"Neurobiol. Aging"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19862-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19862-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19862-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T03:19:19Z","timestamp":1697253559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19862-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,27]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["19862"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-19862-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,27]]},"assertion":[{"value":"5 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6034"}}